Controller medications, also known as daily maintenance medications, are a critical tool for managing asthma — reducing daily ...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). A first-in-class ...

This study highlights the benefits of anti-inflammatory inhalers in asthma management, showing reduced complications and ...

There is a need to develop new anti-inflammatory therapies for this disease. This article critically reviews clinical trial data of novel anti-inflammatory drugs in asthma, encompassing specific ...

[1] All of these pathophysiologic features are largely represented in asthma, and therefore, anticholinergic drugs have been considered to be of potential interest in the treatment of asthma.

Researchers at National Jewish Health and colleagues have identified a mechanism involved in the formation of mucus plugs in ...

Over 40 companies are working on more than 50 therapies for severe asthma. The severe asthma market is growing due to a ...

While current treatments only address symptoms, Ellorarxine shows promise in tackling the underlying causes of the disease. This study is another strong indication of how promising our novel drug ...

Asthma is associated with memory problems in children, a new study has found. Further, the early onset of asthma might worsen ...